NCT07194265
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
Recruiting
NAAges 18+InterventionalTreatmentAnteris Technologies Ltd.
~1,650 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:TAVR with DurAVR® THVTAVR with SAPIEN THV series or the Evolut THV series
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Composite of all-cause mortality, all stroke and cardiovascular hospitalization
Measured over 1 Year
Conditions
Where it's being run
1 sites across 1 statesCapital Region of Denmark1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Composite of all-cause mortality, all stroke and cardiovascular hospitalization1 Year
Composite of all-cause mortality, all stroke and cardiovascular hospitalization